| Snapshot: CBISCANNABIS SCIENCE INC 0.0735 |
Print Format 
| |
Detailed Quote 
 CBIS currently has no events. EventsCannabis Science, Inc., a development stage company, engages in the development, production, and commercialization of phytocannabinoid-based pharmaceutical products. Environmental, Social & Governance Summary (ESG) ESG ratings enable you to leverage independent ESG research to evaluate how companies are managing ESG risks and addressing ESG opportunities. Log in for more information Full Time Employees: -- www.cannabisscience.com 6946 North Academy Boulevard, Suite B 254 1-888-889-0888 | Analyst OpinionsThe Equity Summary Score is an accuracy-weighted sentiment derived from the ratings of independent research providers on Fidelity.com. It uses the past relative accuracy of the providers in determining the emphasis placed on any individual opinion. Learn More.... Log in to view the Equity Summary Score for CBIS Research Reports Company Research Highlights® Report (PDF) |
| CBIS | Industry Average | Percentile in Industry | |
|---|---|---|---|
| Market Capitalization | -- | -- | -- |
| Beta (1 Year Annualized) | -- | -- | -- |
EPS (TTM)  | -- | -- | -- |
 (0) (0)Scroll down for more posts ▼
|
